Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006577

President sold 15,000 shares at an average $56.28 ($844,163)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-29 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-29 Sale : show line 2 in the form −8,294 $55.77 $462,556 6,706 D
2021-01-29 Sale : show line 3 in the form −4,910 $56.60 $277,906 1,796 D
2021-01-29 Sale : show line 4 in the form −1,796 $57.74 $103,701 0 D
Open-market sales · 15,000 sh · avg $56.28 · $844,163

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-29 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −15,000 95,000 D
Loading xslF345X03/doc4.xml…